Biostability, durability and calcification of cryopreserved human pericardium after rapid glutaraldehyde-stabilization versus multistep adapt® treatment in a subcutaneous rat model

European Journal of Cardio-thoracic Surgery

Volumn 45, Issue 4, 2014, Pages

  Neethling, William ^a   Brizard, Christian ^b,c   Firth, Laura ^a   Glancy, Ross ^d  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d FREMANTLE HOSPITAL   (Australia)

Author keywords

Calcification; Glutaraldehyde; Pericardium (bovine); Pericardium (human)

Indexed keywords

CALCIUM; DEOXYCHOLIC ACID; GLUTARALDEHYDE; MAGNESIUM CHLORIDE; PRONASE; PROTEINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; CALCIFICATION; CONTROLLED STUDY; CROSS LINKING; CRYOPRESERVATION; HISTOLOGY; HUMAN; NONHUMAN; PERICARDIUM; PRIORITY JOURNAL; RAT; TEMPERATURE; THERMOSTABILITY; ANALYSIS OF VARIANCE; ANIMAL; BOVINE; CALCINOSIS; CHEMISTRY; DRUG EFFECTS; MALE; MATERIALS TESTING; MICROSCOPY; PATHOLOGY; PROCEDURES; WISTAR RAT;

ANALYSIS OF VARIANCE; ANIMALS; CALCINOSIS; CALCIUM; CATTLE; CRYOPRESERVATION; GLUTARAL; HUMANS; MALE; MATERIALS TESTING; MICROSCOPY; PERICARDIUM; RATS; RATS, WISTAR;

EID: 84896466677     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1093/ejcts/ezt623     Document Type: Article

References (23)

1. Mirsadraee S, Wilcox HE, Korossis SA, Kearney JN, Watterson KG, Fisher J et al. Development and characterization of an acellular human pericardial matrix for tissue engineering. Tissue Eng 2006;12:763-73.
2. Uva MS, SousaM, Galletti L, Lacour-Gayet F, Piot D, Serraf A et al. Surgery for congenital mitral valve disease in the first year of life. J Thorac Cardiovasc Surg 1995;109:164-76.
3. Stellin G, Bortolotti U, Mazzucco A, Faggian G, Guerra F, Daliento L et al. Repair of congenitally malformed mitral valve in children. J Thorac Cardiovasc Surg 1988;95:480-5.
4. Atik FA, Afiune JY, Caneo LF. Autologous pericardium patch aneurysm after ventricular septal defect closure and arterial switch operation. J Card Surg 2009;24:479-80.
5. Cohen O, De La Zerda DJ, FishbeinMC, Calderon CA, Laks H. Pathologic findings in pericardium and native valve tissues after aortic valve-sparing with autologous pericardial leaflet extension. J Heart Valve Dis 2007;16:230-4.
6. Kumar SP, Prabahkar G, Kumar M, Kumar N, Shahid M, Ali ML et al. Comparison of fresh and glutaraldehyde-treated autologous stented pericardium as pulmonary valve replacement. J Card Surg 1995;10:545-51.
7. Kawashima Y, Nakano S, Kato M, Danno M, Sato K. Fate of pericardium utilized for the closure of ventricular septal defect: postoperative ventricular septal aneurysm. J Thorac Cardiovasc Surg 1974;68:209-18.
8. Oppido G, Davies B, McMullan DM, Cochrane AD, Cheung MM, D'Udekem Y et al. Surgical treatment of congenital mitral valve disease: midterm results of a repair-oriented policy. J Thorac Cardiovasc Surg 2008;135:1313-20.
9. McMullan DM, Oppido G, Davies B, Kawahira Y, Cochrane AD, d'Udekem D'Acoz Y et al. Surgical strategy for the bicuspid aortic valve: tricuspidization with cusp extension versus pulmonary autograft. J Thorac Cardiovasc Surg 2007;134:90-8.
10. Neethling WML, Hodge AJ, Glancy R. Mitigation of calcification and cytotoxicity of a glutaraldehyde-preserved bovine pericardial matrix: improved biocompatibility after extended implantation in the subcutaneous rat model. J Heart Valve Dis 2010;19:778-85.
11. Mako WJ, Shah A, Vesely I. Mineralization of glutaraldehyde-fixed porcine aortic valve cusps in the subcutaneous rat model: analysis of variations in implant site and cuspal quadrants. J Biomed Mater Res 1999;45:209-13.
12. Richards FM, Knowles JR. Glutaraldehyde as a protein cross-linking reagent. J Mol Biol 1968;37:231-3.
13. Neethling WML, Glancy R, Hodge AJ. Glutaraldehyde-fixed kangaroo aortic wall tissue: histology, crosslink stability and calcification potential. J Biomed Mater Res Part B Appl Biomater 2003;66B:356-63.
14. Girardot JM, Girardot MN. Amide cross-linking: an alternative to glutaraldehyde fixation. J Heart Valve Dis 1965;5:518-25.
15. Björk VO, Hultquist G. Teflon and pericardial aortic prostheses. J Thorac Cardiovasc Surg 1967;54:465-70.
16. Dahm M, Prüfer D, Mayer E, Groh E, Choi H, Oelert H. Early failure of an autologous pericardium aortic heart valve (ATCV) prosthesis. J Heart Valve Dis 1998;7:30-3.
17. Khaghani A, Mankad P, Dhalla N, Radley-Smith R, Yacoub M. Aortic valve replacement using unstented dura or calf pericardium: early and medium term results. J Am Coll Cardiol 1987;9:8A.
18. Duran CM, Gometza B, Kumar M, Gallo R, Martin-Duran R. Aortic valve replacement with freehand autologous pericardium. J Thorac Cardiovasc Surg 1995;110:511-6.
19. Duran CM, Gometza B, Kumar N, Gallo R, Bjornstad K. From aortic cusp extension to valve replacement with stentless pericardium. Ann Thorac Surg 1995;60:S428-432.
20. Liao K, Frater RW, LaPietra A, Ciuffo G, Ilardi CF, Seifter E. Time-dependent effect of glutaraldehyde on the tendency to calcify of both autografts and xenografts. Ann Thorac Surg 1995;60(2 Suppl):S343-347.
21. Lim H-G, Kim SH, Choi SY, Kim YJ. Anticalcification effects of decellularization, solvent, and detoxification treatment for genipin and glutaraldehyde fixation of bovine pericardium. Eur J Cardiothorac Surg 2012;41:383-90.
22. Liu X, Han L, Song Z, Tan M, Gong D, Xu Z. Aortic valve replacement with autologous pericardium: long-term follow-up of 15 patients and in vivo histopathological changes of autologous pericardium. Interact CardioVasc Thorac Surg 2013;16:123-8.
23. Neethling WM, Yadav S, Hodge AJ, Glancy R. Enhanced biostability and biocompatibility of decellularized bovine pericardium, crosslinked with an ultra-low concentration monomeric aldehyde and treated with ADAPT. J Heart Valve Dis 2008;17:456-63.